Inventor · disambiguated record
Michael Huang
Also filed as: HUANG MICHAEL · HUANG MICHAEL FANGCHING
18 granted patents·17 pending applications·81 citations·filing 2005–2024
93Inventor score
Files withSPRUCE BIOSCIENCES INC11AUSPEX PHARMACEUTICALS INC9AMMAX BIO INC6ACCESS BUSINESS GROUP INT LLC3COSMO TECHNOLOGIES LTD3
Top patents by PatentIndex Score
35 records- 0195US11351177B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2021·Granted Jun 7, 2022·7 cites·21 claims
- 0295US11344557B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2020·Granted May 31, 2022·7 cites·27 claims
- 0395US11311549B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2021·Granted Apr 26, 2022·7 cites·21 claims
- 0495US11007201B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2020·Granted May 18, 2021·14 cites·19 claims
- 0594US12115166B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·21 claims
- 0694US10849908B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2019·Granted Dec 1, 2020·16 cites·25 claims
- 0789US11752096B2Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumorsAMMAX BIO INC·Filed 2022·Granted Sep 12, 2023·1 cites·18 claims
- 0888US11419822B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2021·Granted Aug 23, 2022·1 cites·13 claims
- 0988US10959996B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·5 cites·40 claims
- 1087US2024316035A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1185US7348034B2Plant based formulations for improving skin moisture, texture, and appearanceACCESS BUSINESS GROUP INT LLC·Filed 2005·Granted Mar 25, 2008·16 cites·19 claims
- 1281US2023321112A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1380US2025073170A1High concentration formulations of anti-csf1 and anti-csf1r antibodiesAMMAX BIO INC·Filed 2024·Application pending·0 cites
- 1478US2022143037A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1577US12178915B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2022·Granted Dec 31, 2024·0 cites·10 claims
- 1677US12016858B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·40 claims
- 1775US11446291B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Sep 20, 2022·0 cites·30 claims
- 1874US11357772B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Jun 14, 2022·0 cites·44 claims
- 1974US7419689B2Plant-based formulations for improving liver healthACCESS BUSINESS GROUP INT LLC·Filed 2005·Granted Sep 2, 2008·3 cites·4 claims
- 2072US2020163888A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECH LIMITED·Filed 2019·Application pending·0 cites
- 2172US2024016730A1Targeted delivery of anti-csf1r antibodiesAMMAX BIO INC·Filed 2023·Application pending·0 cites
- 2272US2024261300A1Methods of treating congenital adrenal hyperplasiaSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2371US11564917B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted Jan 31, 2023·0 cites·32 claims
- 2470US11648244B2Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted May 16, 2023·0 cites·23 claims
- 2566US2021361664A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2664US2022133742A1Methods of treating congenital adrenal hyperplasiaSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2761US2017151227A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2859US2014187517A1Method for treating intestinal diseases presenting at least one inflammatory componentSANTARUS INC·Filed 2014·Application pending·0 cites
- 2959US2016287574A1Methods for the treatment of abnormal involuntary movement disordersAUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3059US2023152330A1Detection and treatment of idiopathic pulmonary fibrosisAMMAX BIO INC·Filed 2022·Application pending·0 cites
- 3158US2013209559A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 3258US2013225537A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 3358US2015017239A1Method for treating intestinal diseases presenting at least one inflammatory componentCOSMO TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 3457US7718201B2Method of inducing liver phase II enzymesACCESS BUSINESS GROUP INT LLC·Filed 2008·Granted May 18, 2010·0 cites·4 claims
- 3550US2006198872A1Plant based dietary supplement for improving the duration and quality of sleepIKONTE CHIOMA·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →